JP2013543881A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543881A5 JP2013543881A5 JP2013540410A JP2013540410A JP2013543881A5 JP 2013543881 A5 JP2013543881 A5 JP 2013543881A5 JP 2013540410 A JP2013540410 A JP 2013540410A JP 2013540410 A JP2013540410 A JP 2013540410A JP 2013543881 A5 JP2013543881 A5 JP 2013543881A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- mesoporous silica
- active ingredient
- range
- croscarmellose sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 14
- 239000000203 mixture Substances 0.000 claims 7
- 239000000377 silicon dioxide Substances 0.000 claims 7
- 238000009472 formulation Methods 0.000 claims 6
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 229960001681 croscarmellose sodium Drugs 0.000 claims 4
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 4
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000011148 porous material Substances 0.000 claims 2
- 239000007916 tablet composition Substances 0.000 claims 2
- 231100001125 band 2 compound Toxicity 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10192938 | 2010-11-29 | ||
| EP10192938.8 | 2010-11-29 | ||
| PCT/EP2011/071186 WO2012072580A1 (en) | 2010-11-29 | 2011-11-28 | Compressed formulations of ordered mesoporous silicas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013543881A JP2013543881A (ja) | 2013-12-09 |
| JP2013543881A5 true JP2013543881A5 (https=) | 2014-03-06 |
Family
ID=43827090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013540410A Pending JP2013543881A (ja) | 2010-11-29 | 2011-11-28 | 秩序化したメソポーラスシリカの圧縮製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20130243833A1 (https=) |
| EP (1) | EP2646005B1 (https=) |
| JP (1) | JP2013543881A (https=) |
| ES (1) | ES2744926T3 (https=) |
| PL (1) | PL2646005T3 (https=) |
| WO (1) | WO2012072580A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201212866D0 (en) * | 2012-07-20 | 2012-09-05 | Formac Pharmaceuticals Nv | Dry granulates of mesoporous silica powders |
| WO2016041992A1 (en) | 2014-09-15 | 2016-03-24 | Grace Gmbh & Co. Kg | Active-loaded particulate materials for topical administration |
| US12459829B2 (en) | 2018-11-07 | 2025-11-04 | Disruptive Pharma Ab | Amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037705A1 (en) | 1997-12-09 | 1999-07-29 | The Regents Of The University Of California | Block polymer processing for mesostructured inorganic oxide materials |
| US20060018966A1 (en) | 2003-07-22 | 2006-01-26 | Lin Victor S | Antimicrobial mesoporous silica nanoparticles |
| US7563451B2 (en) * | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
| JP5519639B2 (ja) | 2008-04-28 | 2014-06-11 | フォーマック ファーマシューティカルズ ナムローゼ フェンノートシャップ | 秩序化したメソポーラスシリカ材料 |
| EP2393485B1 (en) * | 2009-02-06 | 2015-07-29 | Gilead Sciences, Inc. | Bilayer tablets comprising elvitegravir, cobicistat, emtricitabine and tenofovir |
-
2011
- 2011-11-28 US US13/988,687 patent/US20130243833A1/en not_active Abandoned
- 2011-11-28 ES ES11822806T patent/ES2744926T3/es active Active
- 2011-11-28 WO PCT/EP2011/071186 patent/WO2012072580A1/en not_active Ceased
- 2011-11-28 JP JP2013540410A patent/JP2013543881A/ja active Pending
- 2011-11-28 EP EP11822806.3A patent/EP2646005B1/en active Active
- 2011-11-28 PL PL11822806T patent/PL2646005T3/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2601127T3 (es) | Derivado de pirazol y su uso con fines médicos | |
| JP2015007131A5 (https=) | ||
| NZ729172A (en) | Combination formulation of two antiviral compounds | |
| JP2010132654A5 (https=) | ||
| JP2015078230A5 (https=) | ||
| JP2010527347A5 (https=) | ||
| JP2016501828A5 (https=) | ||
| CL2013000677A1 (es) | Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn. | |
| JP2014205701A5 (https=) | ||
| JP2010534220A5 (https=) | ||
| CN104661649A (zh) | 包含替格瑞洛的固态口服医药制剂 | |
| HRP20171824T1 (hr) | (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI S DVOJNOM AKTIVNOŠĆU INVERZNIH AGONISTA H1 I ANTAGONISTA 5-HT2A | |
| JP2015514739A5 (https=) | ||
| JP2013166781A5 (https=) | ||
| RU2015143475A (ru) | Продукт и способ лечения диареи | |
| JP2013543881A5 (https=) | ||
| JP2009542678A5 (https=) | ||
| PL2647637T3 (pl) | Pochodna purynylopirydynyloamino-2,4-dlfluorofenylo-sulfonamidu, jej farmaceutycznie dopuszczalna sól, sposób jej wytwarzania oraz zawierająca ją jako składnik aktywny kompozycja farmaceutyczna o aktywności hamującej kinazę Raf | |
| MX374106B (es) | Una composicion farmaceutica que contiene candesartan cilexetilo y amlodipina. | |
| JP2011516544A5 (https=) | ||
| JP2015129124A5 (https=) | ||
| JP2015120758A5 (https=) | ||
| IT1401284B1 (it) | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). | |
| EA033291B1 (ru) | Единица дозирования, содержащая рамиприл и бисопролола гемифумарат, способ ее получения и способ лечения гипертензии | |
| WO2014006636A3 (en) | Stable compositions of fesoterodine |